AMAnna Metafa

Anna Metafa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna Metafa has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dynamic AI-assisted Ipsilateral Tissue Matching for Digital Breast Tomosynthesis

    by Stephen James Morrell, Michael Huetel, Oeslle de Lucena, Cristina Alfaro Vergara, Georgiana Zamfir, Charlottefreya Longman, Rumana Rahim, Sophia O’brien, Elizabeth S. McDonald, Samantha Zuckerman, et al.

    Structured Purpose: To compare Digital Breast Tomosynthesis (DBT) tissue matching errors with and without artificial intelligence (AI) assistance to typical screen-detected breast tumor sizes, evaluating whether AI ameliorates lesion mislocalization beyond tumor boundaries, especially for nonexpert radiologists. The technology category is deep learning. Materials and Methods: This multicenter retrospective feasibility study conducted in April 2022 – July 2023 included 12 radiologists (mean age, 42 years ± 8) interpreting 94 lesion regions of interest in 30 women. Readers performed annotations with and without AI assistance after a minimum four-week washout period. The root mean square errors (RMSE) and maximum distance errors (MDE) were measured relative to consensus references. Stratifications included radiologist expertise ( ≥ 5 vs < 5 years), lesion abnormal-ity, and AI warnings. The Wilcoxon signed-rank test was used to assess statistical significance. Results: Across all abnormal lesions, mean RMSE was 32% higher without AI (11.70 mm vs 8.88 mm , p = .049), and mean maximum distance errors were 37.5% higher (20.68 mm vs 15.08 mm , p = .036). Non-expert radiologists showed the largest benefit: for abnormal lesions without AI warnings, RMSE was 61.9% higher without AI (12.20 mm vs 7.57 mm , p = .010) and maximum distance error was 67.5% higher (15.76 mm vs 9.47 mm , p = .028). These reductions are clinically relevant given typical screen-detected breast tumor sizes (median, 13 mm [IQR: 9–20]). Conclusion: AI-assisted tissue matching significantly reduced DBT localization errors, particularly for non-experts handling challenging cases. By keeping errors below typical tumor dimensions, AI may improve diagnostic precision and reduce risks of missed or mischaracterized lesions. Summary Statement: Dynamic artificial intelligence assisted tissue matching in digital breast tomosynthesis improves localization accuracy for non-expert radiologists, with errors in abnormal cases significantly larger (67.5%, p ≤ 0.05) without assistance. Key Points: In this multicenter retrospective study of 94 Regions of Interest (ROI) analyzed by 12 radiologists across 5 hospitals, manual tissue matching was found to have errors 32% higher in abnormal cases than AI-assisted tissue matching ( p < 0.05). For non-expert radiologists interpreting abnormal cases (excluding cases with AI warnings) without AI assistance, the root mean squared distance errors (RMSE) were found to be 61.9% higher (12.20 mm vs 7.57 mm , p < 0.01) and the maximum distance errors (MDE) was 67.6% higher (15.76 mm vs 9.47 mm , p < 0.05) than when using AI assistance. For challenging cases, many non-expert readers’ MDE without AI assistance (75th percentile: 20.21 mm ) exceeded the largest tumor dimensions (75th percentile: 20 mm ), while AI-assisted errors (75th percentile: 11.94 mm , p < 0.05) remained within median tumor sizes (12 mm ), potentially preventing correlation with non-lesion tissue.

  • Two cases of breast pseudoaneurysm following core biopsy: A very rare complication with different treatment options

    by Champika Jayathilake, Thamara Uyangoda, Dimitris Kitsos, Ali Sever, Abdul Kasem, Anna Metafa

    Introduction: Breast pseudoaneurysm is a rare complication following breast interventional procedures such as core biopsies and vacuum-assisted biopsies. The occurrence of pseudoaneurysm increases with the conditions of increased breast vascularity like cancer, pregnancy and lactation. Case Report: We present two cases of pseudoaneurysm formation secondary to core biopsies of the breasts. The first patient was an 82-year-old female patient who presented with breast swelling and bruising after multiple clinical core biopsies of the left breast. Our second patient was a 47-year-old lady who presented with a palpable lump following ultrasound-guided core biopsies of the left breast. Ultrasound showed hypoechoic pulsating area with evidence of internal colour flow in connection with a vessel in both cases. Imaging appearances were in keeping with a pseudoaneurysm of the breast. Discussion: Most pseudoaneurysms are secondary to interventional procedures in the breast. Common clinical presentation is a pulsatile, palpable mass at the biopsy site soon after the biopsy or later. On B mode imaging, it presents as a well-circumscribed mass of mixed echogenicity. Typical waveform in spectral Doppler and ‘yin-yang’ sign in colour Doppler is demonstrated with a turbulent internal flow. There are different treatment options to manage pseudoaneurysms of the breast. Conclusion: Pseudoaneurysm of the breast should be considered if a patient presents with a breast mass/lump close to a recent biopsy site. On clinical examination, pulsatility of the mass should raise the suspicion and definite diagnosis can be made with spectral and colour Doppler US scan.